CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase I Open Label Clinical Trial Evaluating the Safety and Anti-Tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha Fetoprotein (AFPᶜ³³²T) in HLA-A2 Positive Subjects With Advanced Hepatocellular Carcinoma (HCC) or Other AFP Expressing Tumor Types

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03132792
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-18T00:02:10.136453+00:00
Published At: 2026-06-17T00:00:00+00:00
Record Updated At: 2026-06-17
Results Posted At: 2026-06-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatocellular Cancer", "AFP Expressing Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-17"
protocolSection.identificationModule.nctId: "NCT03132792"
protocolSection.identificationModule.officialTitle: "A Phase I Open Label Clinical Trial Evaluating the Safety and Anti-Tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha Fetoprotein (AFP\u1d9c\u00b3\u00b3\u00b2T) in HLA-A2 Positive Subjects With Advanced Hepatocellular Carcinoma (HCC) or Other AFP Expressing Tumor Types"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-06-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.